These results indicate that the combination of D,L-methadone and doxorubicin sensitizes BCP-ALL cells for apoptosis via the activation of caspases and downregulation of XIAP and Bcl-xL. The gene discussed is BCL2L1; the disease is acute lymphoblastic leukemia.